• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

7/3/2007 Telecon - RECOTHROM

FOOD AND DRUG ADMINISTRATION
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH

Telecon

Date: July 3, 2007
To: File STN 125248/0 ZymoGenetics Thrombin (Recombinant)
From: Mark A. Shields, HFM-380; RPMB, DBA, OBRR, CBER; (301) 827-6173 FAX (301) 827-2857
Subject: 02-Jul-07 Telecon.

FDA Attendees: Mark Shields

ZymoGenetics Participants:
Dale Goodloe.

Discussion Points;

I called Mr. Goodloe to request he email me the names of the ZymoGenetics participants in the telecom held yesterday (02-Jul07). I also requested he submit their version of meeting minutes as an amendment to the BLA for the record.

He agreed to provide.

END

 

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002